Regeneron Pharmaceuticals, Inc. SEC filings REGN
Regeneron Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 29, 2017. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 30, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Oct 6, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2026 | Sep 24, 2026 |
| N-PX | Filing | Aug 20, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 6, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 12, 2026 |
| 10-Q | Quarterly report | Apr 29, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2026 | Apr 29, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 8, 2026 | Apr 8, 2026 |
| 10-K | Annual report | Feb 4, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 30, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 10-Q | Quarterly report | Oct 28, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 6, 2025 | Oct 6, 2025 |
| 10-Q | Quarterly report | Aug 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 13, 2025 |
| 10-Q | Quarterly report | Apr 29, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2025 | Apr 29, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 13, 2025 |
| UPLOAD | Letter from the SEC | Apr 17, 2025 | — |
| PRE 14A | Preliminary proxy statement | Apr 7, 2025 | Jun 13, 2025 |
| CORRESP | Letter to the SEC | Apr 3, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2025 | — |
| 10-K | Annual report | Feb 5, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 4, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| S-3ASR | Automatic shelf registration | Oct 31, 2024 | — |
| 10-Q | Quarterly report | Oct 31, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 7, 2024 | Oct 7, 2024 |
| UPLOAD | Letter from the SEC | Sep 11, 2024 | — |
| CORRESP | Letter to the SEC | Aug 1, 2024 | — |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| UPLOAD | Letter from the SEC | Jul 22, 2024 | — |
| 8-K |
Current report
Results of operations
|
Jul 8, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 14, 2024 |
| CORRESP | Letter to the SEC | May 20, 2024 | — |
| UPLOAD | Letter from the SEC | May 9, 2024 | — |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 14, 2024 |
| 10-K | Annual report | Feb 5, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 2, 2024 | Feb 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 31, 2024 | Jan 26, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 5, 2023 | Oct 5, 2023 |
| SC TO-T/A | Filing | Sep 25, 2023 | — |
| SC TO-T/A | Filing | Sep 12, 2023 | — |
| 8-K/A |
Amended current report
Shareholder vote results
|
Sep 8, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 8, 2023 | Sep 1, 2023 |
| SC TO-T/A | Filing | Sep 8, 2023 | — |
| SC TO-T | Filing | Aug 25, 2023 | — |
| SC TO-C | Filing | Aug 9, 2023 | — |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 14, 2023 | Jun 9, 2023 |
| PX14A6G | Filing | May 18, 2023 | — |
| DEFA14A | Additional proxy material | May 17, 2023 | — |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| ARS | Annual report to shareholders | Apr 21, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 21, 2023 | — |
| DEF 14A | Proxy statement | Apr 21, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2023 | Apr 14, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 10, 2023 | Apr 10, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 29, 2023 | Mar 27, 2023 |
| 10-K | Annual report | Feb 6, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 3, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Dec 20, 2022 | Dec 19, 2022 |
| UPLOAD | Letter from the SEC | Nov 7, 2022 | — |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| CORRESP | Letter to the SEC | Oct 7, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Oct 3, 2022 | Oct 3, 2022 |
| UPLOAD | Letter from the SEC | Sep 21, 2022 | — |
| 10-Q | Quarterly report | Aug 3, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2022 | Aug 3, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Material agreement
|
Jun 2, 2022 | Jun 1, 2022 |
| SC TO-T/A | Filing | May 31, 2022 | — |
| SC TO-T/A | Filing | May 20, 2022 | — |
| SC TO-T/A | Filing | May 11, 2022 | — |
| 10-Q | Quarterly report | May 4, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| SC TO-T | Filing | May 2, 2022 | — |
| DEFA14A | Additional proxy material | Apr 21, 2022 | — |
| DEFA14A | Additional proxy material | Apr 21, 2022 | — |
| DEF 14A | Proxy statement | Apr 21, 2022 | Jun 10, 2022 |
| SC TO-C | Sc to-t | Apr 19, 2022 | — |
| 8-K |
Current report
Material agreement, New debt
|
Mar 8, 2022 | Mar 2, 2022 |
| 10-K | Annual report | Feb 7, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2022 | Feb 4, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| S-3ASR | Automatic shelf registration | Nov 4, 2021 | — |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 16, 2021 | Sep 14, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2021 | Jun 11, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| DEFA14A | Additional proxy material | May 3, 2021 | — |
| DEFA14A | Additional proxy material | Apr 23, 2021 | — |
| DEFA14A | Additional proxy material | Apr 23, 2021 | — |
| DEF 14A | Proxy statement | Apr 23, 2021 | Jun 11, 2021 |
| 10-K | Annual report | Feb 8, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 5, 2021 | Feb 5, 2021 |
| 8-K |
Current report
Material agreement
|
Jan 15, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2021 | Dec 31, 2020 |
| UPLOAD | Letter from the SEC | Jan 4, 2021 | — |
| CORRESP | Letter to the SEC | Dec 7, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2020 | — |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Material agreement
|
Aug 19, 2020 | Aug 18, 2020 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Aug 12, 2020 | Aug 7, 2020 |
| 424B5 | Prospectus supplement | Aug 11, 2020 | — |
| FWP | Free writing prospectus | Aug 7, 2020 | — |
| 424B3 | Prospectus | Aug 7, 2020 | — |
| 10-Q | Quarterly report | Aug 5, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2020 | Aug 5, 2020 |
| CT ORDER | Filing | Jul 15, 2020 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 7, 2020 | Jul 6, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2020 | Jun 12, 2020 |
| S-8 | Employee stock plan registration | Jun 16, 2020 | — |
| DEFA14A | Additional proxy material | Jun 8, 2020 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 29, 2020 | May 25, 2020 |
| 424B3 | Prospectus | May 28, 2020 | — |
| 424B3 | Prospectus | May 26, 2020 | — |
| FWP | Free writing prospectus | May 26, 2020 | — |
| FWP | Free writing prospectus | May 26, 2020 | — |
| 10-Q | Quarterly report | May 5, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 5, 2020 | May 5, 2020 |
| DEFA14A | Additional proxy material | Apr 24, 2020 | — |
| DEFA14A | Additional proxy material | Apr 24, 2020 | — |
| DEF 14A | Proxy statement | Apr 24, 2020 | Jun 12, 2020 |
| 8-K |
Current report
Material agreement
|
Apr 7, 2020 | Apr 5, 2020 |
| 10-K | Annual report | Feb 7, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2020 | Feb 6, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2019 | Nov 5, 2019 |
| CT ORDER | Filing | Oct 8, 2019 | — |
| 10-Q | Quarterly report | Aug 6, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2019 | Aug 6, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 19, 2019 | Jun 14, 2019 |
| CT ORDER | Filing | May 14, 2019 | — |
| CT ORDER | Filing | May 9, 2019 | — |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
May 7, 2019 | May 7, 2019 |
| 10-Q | Quarterly report | May 7, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 7, 2019 | May 7, 2019 |
| 8-K |
Current report
Material agreement, New debt
|
May 3, 2019 | May 2, 2019 |
| DEFA14A | Additional proxy material | Apr 26, 2019 | — |
| DEFA14A | Additional proxy material | Apr 26, 2019 | — |
| DEF 14A | Proxy statement | Apr 26, 2019 | Jun 14, 2019 |
| 8-K |
Current report
Material agreement
|
Apr 10, 2019 | Apr 8, 2019 |
| 10-K | Annual report | Feb 7, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2019 | Feb 6, 2019 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Jan 7, 2019 | Jan 2, 2019 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Dec 17, 2018 | Dec 14, 2018 |
| S-3ASR | Automatic shelf registration | Nov 13, 2018 | — |
| 10-Q | Quarterly report | Nov 6, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2018 | Nov 6, 2018 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 12, 2018 | Oct 10, 2018 |
| 10-Q | Quarterly report | Aug 2, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2018 | Aug 2, 2018 |
| CT ORDER | Filing | Jul 26, 2018 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2018 | Jun 8, 2018 |
| 10-Q | Quarterly report | May 3, 2018 | Mar 31, 2018 |
| 8-K |
Current report
Results of operations
|
May 3, 2018 | May 3, 2018 |
| DEFA14A | Additional proxy material | Apr 23, 2018 | — |
| DEFA14A | Additional proxy material | Apr 23, 2018 | — |
| DEF 14A | Proxy statement | Apr 23, 2018 | Jun 8, 2018 |
| 10-K | Annual report | Feb 8, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Results of operations
|
Feb 8, 2018 | Feb 8, 2018 |
| 8-K |
Current report
Officer or director change
|
Jan 18, 2018 | Jan 15, 2018 |
| CT ORDER | Filing | Jan 9, 2018 | — |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Jan 8, 2018 | Jan 7, 2018 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2018 | Jan 2, 2018 |
| CT ORDER | Filing | Dec 7, 2017 | — |
| 10-Q | Quarterly report | Nov 8, 2017 | Sep 30, 2017 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2017 | Nov 8, 2017 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- REGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NY
- Headquarters
- Tarrytown, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 872589
- Former names
- REGENERON PHARMACEUTICALS INC (until Jun 19, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.